GUK1 activation is a metabolic liability in lung cancer
Abstract
No abstract availableKeywords
Funding Information
- Ludwig Center at Harvard (U01CA267827)
- Ludwig Center at Harvard (R01CA273461)
- Ludwig Center at Harvard (R01CA213062)
- National Cancer Institute (NIH 5 P30 CA06516)
- National Institute of General Medical Sciences (R01 CA240317)
- National Institute of General Medical Sciences (R01 GM132129)
- Foundation for the National Institutes of Health (R01 CA240317)
- Foundation for the National Institutes of Health (R01 GM132129)
- Foundation for the National Institutes of Health (K12CA087723)
- Joslin Diabetes Center (GM67945)
- Joslin Diabetes Center (R01 CA164273)
- Lung Cancer Research Foundation
- National Institutes of Health
- American Cancer Society
- A Breath of Hope Lung Foundation
- Life Sciences Research Foundation
This publication has 58 references indexed in Scilit:
- Obesity Shapes Metabolism in the Tumor Microenvironment to Suppress Anti-Tumor ImmunityCell, 2020
- Frequent genomic alterations and better prognosis among young patients with non-small-cell lung cancer aged 40 years or youngerClinical and Translational Oncology, 2018
- Understanding the Intersections between Metabolism and Cancer BiologyCell, 2017
- Blocking the PI3K pathway enhances the efficacy of ALK-targeted therapy in EML4-ALK-positive nonsmall-cell lung cancerTumor Biology, 2014
- Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted DrugsJAMA, 2014
- CHARMM: The biomolecular simulation programJournal of Computational Chemistry, 2009
- CHARMM‐GUI: A web‐based graphical user interface for CHARMMJournal of Computational Chemistry, 2008
- Crystal structure of unligated guanylate kinase from yeast reveals GMP-induced conformational changesJournal of Molecular Biology, 2001
- Peptide Folding: When Simulation Meets ExperimentAngewandte Chemie International Edition, 1999
- VMD: Visual molecular dynamicsJournal of Molecular Graphics, 1996